Five-year findings show topical imiquimod 5% effective for low-risk BCC
Findings from a five-year trial of 5% imiquimod cream for treating superficial and nodular basal cell carcinomas show sustained benefits...
top of page
it's where dermatology lives
Featured Posts
bottom of page